Latest News about General
Recent news which mentions General
Developer Of EpiPen Alternative Aquestive Stock Undervalued Despite Strong Clinical Data, Analyst Sees Huge Upside
December 17, 2024
From Benzinga
What's Going On With Larimar Therapeutics Stock On Tuesday?
December 17, 2024
From Benzinga
Walmart Begins Program That Has Employees Wear Bodycams For Safety
December 17, 2024
From Benzinga
MidWestOne's Restructuring Expected To Boost Margins By 70 Basis Points Starting In Q4: Analyst
December 17, 2024
From Benzinga
Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
December 17, 2024
From Benzinga
What's Going On With Children's Place Stock Today?
December 17, 2024
From Benzinga
Nukkleus Rockets Higher: $26M Stake In Iron Dome Supplier RIMON Boosts Defense Ambitions
December 17, 2024
From Benzinga
FDA Rejects Johnson & Johnson's Injectable Version Of Approved Drug For Lung Cancer
December 17, 2024
From Benzinga
'Americans Bought Less But Paid More,' Says Peter Schiff: Experts Digest November Retail Sales Data
December 17, 2024
From Benzinga
Why Is Sidus Space Stock Gaining Tuesday?
December 17, 2024
From Benzinga
From Benzinga
What's Going On With AI Drone Company ZenaTech Stock Today?
December 17, 2024
From Benzinga
NXP Semiconductors Bets Big On Auto Connectivity With $242.5 Million Aviva Links Deal
December 17, 2024
From Benzinga
Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?
December 17, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.